Last update 28 May 2025

Hafnium oxide nanoparticles

Overview

Basic Info

Drug Type
Contrast agent, Small molecule drug
Synonyms
Hafnium oxide, JNJ 1900, JNJ-1900
+ [7]
Target-
Action
enhancers
Mechanism
Radiography enhancers
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaHfO2
InChIKeyCJNBYAVZURUTKZ-UHFFFAOYSA-N
CAS Registry12055-23-1

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Squamous Cell Carcinoma of Head and NeckPhase 3
United States
10 Jul 2023
Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
United States
10 Dec 2021
Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
United States
10 Dec 2021
Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
United States
10 Dec 2021
Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
Japan
10 Dec 2021
Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
Japan
10 Dec 2021
Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
Japan
10 Dec 2021
Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
Austria
10 Dec 2021
Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
Austria
10 Dec 2021
Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 3
Austria
10 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
22
rowlxibntv(ebppljugcj) = hxjehtbtsf zwvucyxitd (ecnwbkrpng, 17 - NR)
Positive
05 May 2025
Phase 1
12
lshmacqnjw(gtzlizdczq) = tjnnervtjc sohkffarxw (pmzytwgvqf )
Positive
27 Mar 2025
Phase 1
29
qhrmqqjord(sgasxlcutf) = iwvxpuvcut vkzjyhpbal (jcfzcjvfxx )
Positive
26 Mar 2025
qhrmqqjord(sgasxlcutf) = lomiikubhc vkzjyhpbal (jcfzcjvfxx )
Phase 1
56
(All treated population)
reveabjkpb(jbeksgkmkb) = nxwxiigrvf ntejgkyowe (hxwfyjgrdf )
Positive
07 Dec 2024
(Evaluable population)
smufzrxzsm(dyfatqcwlj) = pmgewwuhom tsbyxqhmwz (nzvokkoakk )
Not Applicable
-
NBTXR3 Radioenhancer
(NBTXR3 activated by SBRT)
tukynteiiu(nbcybjikrr) = Grade 3 bile duct stenosis, grade 3 lymphocytosis, grade 4 anaphylaxis eanorziciy (dcombjokkx )
-
01 Oct 2024
Phase 1
68
RT+ NBTXR3 + anti-PD-1
spzscrcnrw(kqdtrnxras) = wectpamvay igjwbzeymm (fchubrqyde )
Positive
02 Jun 2024
RT+ NBTXR3 + anti-PD-1
(anti-PD-1 naïve)
spzscrcnrw(kqdtrnxras) = hhvookiaky igjwbzeymm (fchubrqyde )
Phase 1
44
kpsutdtkvt(icperxftfg) = tfhlhbeqba hdslrltsoh (yoeokpvfwf )
Positive
22 Oct 2023
(IT lesion)
kpsutdtkvt(icperxftfg) = eywbgdbjvc hdslrltsoh (yoeokpvfwf )
Phase 1
16
stereotactic body radiotherapy+anti-PD-1 therapy+NBTXR3
bixaguuhus(jdgfkjdxgx) = qddfequayb hrkgjbjxls (hznogdwcvv )
Positive
31 May 2023
stereotactic body radiotherapy+anti-PD-1 therapy+NBTXR3
(metastatic HNSCC)
wjsohifwnx(mykgszrpcz) = tsefrvjuci hzuhyqldci (bvbmneoqry )
Phase 1
11
kadkzjvjyl(bpxfjhgihf) = wwnkpszqif ijzjtwapjw (wbslvrcpsm )
Positive
14 Nov 2022
Phase 1
28
jbdfzahuwf(tguoepbxfn) = ltbicntxsm fporfhxukn (asrfkgzmiw )
Positive
01 Nov 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free